microdosing semaglutide for pcos and metformin improve menstrual cyclicity in overweight/obese women with polycystic ovary syndrome: a randomized trial Microdosing Semaglutide: The Gentle GLP-1

L-Cysteine-glutathione Disulfide may act to protect mice against acetaminophen-induced hepatotoxicity, however the D-cysteine adduct was shown to be totally ineffective in this regard

These trials showed that people who used semaglutide over longer periods continued to lose weight or maintain their weight loss

adult obesity rate was a record-high 39.9%, while in 2025, that rate gradually declined to 37%

and, very rarely, vision issues such as irreversible nerve damage in the eye which are usually linked to underlying conditions, such as diabetes

It is recommended to keep a varied and balanced diet and healthy lifestyle

If unsure, contact a licensed medical specialist